医学教育分野別評価基準日本版 v1...医学教育分野別評価基準日本版v1.30...

医学教育分野別評価基準日本版 V1.30

に基づく

筑波大学医学群医学類自己点検評価

2015 年度

医学教育分野別評価基準日本版Ｖ１・３０に基づく筑波大学医学群医学類自己点検評価２０１５年度

27

25

2010 ECFMG(Educational Commission for Foreign Medical Graduates) 2023

USMLE(United States Medical Licensing Examination)

WFME 2003

JACME 2012

2013 WFME

2015 261974

16PBL

78

PCME( )

27 8

3

目次

１．使命と教育成果・・・・・・・・・・・・・・・・・・7

２．教育プログラム・・・・・・・・・・・・・・・・・45

３．学生評価・・・・・・・・・・・・・・・・・109

４．学生・・・・・・・・・・・・・・・・・133

５．教員・・・・・・・・・・・・・・・・・171

６．教育資源・・・・・・・・・・・・・・・・・191

７．プログラム評価・・・・・・・・・・・・・・・・・247

８．統轄および管理運営・・・・・・・・・・・・・・289

９．継続的改良・・・・・・・・・・・・・・・・・311

― 3 ―

7

•

•

•

•

•

― 7 ―

8

1872 5

― 8 ―

9

1963 38 827 1971 46

11

1973 48 101974 49

4 1 100 197651 10 1 15 320 1978 53

800 1978 53 10

2007 19 4

1-1

― 9 ―

10

1.

2.

3.

4.

5.

-26

― 10 ―

11

1.

2. 3.

4.

-26 FD

FD

2015 27

B 1.2.1 7

― 11 ―

12

-4

1.

2. 3.

4.

1-2

2015 27 71

― 12 ―

13

-31

1-1 https://www.tsukuba.ac.jp/about/concept.html

-3 -26 -4

http://igaku.md.tsukuba.ac.jp/igakurui-info 1-2

-4

2015 27 7

― 13 ―

14

2015 27 7

-3 -26 -4

http://igaku.md.tsukuba.ac.jp/igakurui-info

B 1.1.1 1.

B 1.1.2

B 1.1.2

-3

― 14 ―

15

-26 -4


2.

B 1.1.2

B 1.1.2

-3 -26 -4


― 15 ―

16

B 1.1.1

-26

CBT OSCE

B 1.1.2

B 1.1.2

-3 -26 -4


― 16 ―

17

-4 3.

B 1.1.2

B 1.1.2

-3 -26 -4


-4 1.

4.

― 17 ―

18

B 1.1.2

B 1.1.2

-3 -26 -4


B 1.1.2

B 1.1.2

― 18 ―

19

-3 -26 -4


B 1.1.1 4.

B 1.1.2

B 1.1.2

-3 -26 -4


― 19 ―

20

•

•

( ) ( ) PCME

― 20 ―

21

4

2015 27 7

( ) () PCME ( )

1 ( )( )

( ) SP 2015 27 7 1 1-4

― 21 ―

22

1-3 1-4 2015 27 7 15

B 1.2.1

6 5

Q 4.1.1

B 1.2.1

― 22 ―

23

•

•

•

1 1

― 23 ―

24

B 1.2.1

3 B 2.1.2 PBL

PCME

2015 27 7 1 94 89167 72 3 425

5 B 5.1.1

― 24 ―

25

(Center of Planning and Coordination for Medical Education, PCME ) PCME 12 5

7 13 6 7

PCME

13

3FD 3

FD

PCME

2

― 25 ―

26

PCMEFD

C

― 26 ―

27

•

•

― 27 ―

28

B 1.1.1

5-26

――――――――――――――――――――――――――――――――――――――――――――――――――― 1. 2.

Computer Based Testing(CBT) Objective Structured Clinical Examination(OSCE)

3.

4. 5.

―――――――――――――――――――――――――――――――――――――――――――――――――――

6 2005 17CBT OSCE

-19

― 28 ―

29

WG

WG

PCME

M3

― 29 ―

30

-26 -19 Phase Ⅱ Clinical Clerkship Ⅰ Ⅱ

B 1.4.1-19

6-26 -36 1

34 5

6

3

― 30 ―

31

B 1.4.1

-24 5CC

3-23 ―――――――――――――――――――――――――――――――――――――――――――――――――――

CC 1. ― ―

2.

3.

―――――――――――――――――――――――――――――――――――――――――――――――――――

-25entrance 1 3 -36 4

5 6

― 31 ―

32

B 1.4.1

B 1.4.1

-19 Phase Ⅱ Clinical Clerkship Ⅰ Ⅱ -26 -36 -24 -23 CC -25

B 1.4.1

-19 -24I IV

―――――――――――――――――――――――――――――――――――――――――――――――――――

― 32 ―

33

―――――――――――――――――――――――――――――――――――――――――――――――――――

B 1.4.1

B 1.4.1

-19 Phase Ⅱ Clinical Clerkship Ⅰ Ⅱ -24

B 1.1.1 -26

― 33 ―

34

CBT OSCE

B 1.4.1 B 1.4.3

B 1.4.1

B 1.4.1

-26

-26 -36

― 34 ―

35

B 1.4.1

B 1.4.1

-26 -36

5

-23 -24

B 1.4.1

― 35 ―

36

B 1.4.1

-23 CC -24

5Ⅰ

―――――――――――――――――――――――――――――――――――――――――――――――――――

1 -27 1.

2.

1 2 3

4 5

6

7

― 36 ―

37

8 9

10 ―――――――――――――――――――――――――――――――――――――――――――――――――――

Ⅲ -32 1.

2.

1 2

3

4

―――――――――――――――――――――――――――――――――――――――――――――――――――

-19 ―――――――――――――――――――――――――――――――――――――――――――――――――――

• • •

• • • •

• •

• ( ) ( ) ( )

―――――――――――――――――――――――――――――――――――――――――――――――――――

― 37 ―

38

B 1.4.1

B 1.4.1

-27 Ⅰ -32 -19 Phase Ⅱ Clinical Clerkship Ⅰ Ⅱ

B 1.4.1 B 1.4.7

WG

― 38 ―

39

PCME

B 1.4.1 B 1.4.2

-36

-25

― 39 ―

40

WG

-36 -25

3 1 4 1 6 1

1 2 3 4 5

M610 2

― 40 ―

41

WG

― 41 ―

45

•

•

•

•

•

― 45 ―

46

1

( )

6

― 46 ―

47

2004 16

― 47 ―

48

50 78

( )1

5

B 3.1.1 2-1 2-2 2-3

40

2004 16

CBTCBT

― 48 ―

49

CBT

( )

97.1

95.5

96.4

98.9

96.2

98.9

50 60 70 80 90 100

H20

H21

H22

H23

H24

H25

― 49 ―

50

2016 28

2-1 2-2 2003 GP 2-3 44 440-453 2013

Phase Ⅰ Ⅲ

Phase Ⅰ

-26 29 30

― 50 ―

51

( PBL) 1

Team-Based Learning TBL

2-4

PBL

― 51 ―

52

Phase Ⅱ M4 I

CC (Pre-CC)

TBL

M4 9 M6 4 CC CC CC 8 ×7

CC4 ×2 CC8 72-19

Phase Ⅲ

620 -35

1 5

― 52 ―

53

TBL-20 -23 -27 -28 -31 -32 -12 2-5

M5 M6 2

Ⅴ Phase Ⅲ

2-6 -25

PhaseⅠ PBL

PCME10

CBT

― 53 ―

54

CC3 2-7

FD 2-8 4

FD

800

SP

e-learning manaba

FD

Phase Ⅰ 2016

28 TBL

― 54 ―

55

FDFD

TBL e-learning

-26 -34 M1 M4 -26 29 30 M M3

2-4 2-5 2-6 M5 2-7 M5CC 2014 4 M5 2-8 26 FD

-19 Phase Ⅱ Clinical Clerkship Ⅰ Ⅱ -35 M6

B 1.1.1 3

2

3

― 55 ―

56

Q 9.0.4

FD B 3.2.3 Q 3.2.2

2

2004 16 4

FDPCME

2-9 Web

― 56 ―

57

19.8

C

2-9 http://diversity.tsukuba.ac.jp/

PBLⅠ -27

1 2 150

2 91

-28 1 2 Ⅱ 4

TBL

TBL

― 57 ―

58

CBT 4 6

TBL

C

-27 Ⅰ -28 Ⅱ

― 58 ―

59

•

•

6

PBL

1 9 2 6

― 59 ―

60

2 Ⅰ PBLⅡ

3 Ⅱ 2

PBL

4

4 6 3

5 9 6 4 64

1 6

― 60 ―

61

FD

-3 -4


-274 -34

6

( -36)

2

5

5 6

― 61 ―

62

( )2015 27 4

52-10 2-11

WG 2015

27 1

WG

Early Research Exposure

-3 -4

http://igaku.md.tsukuba.ac.jp/igakurui-info -27 M1

-34 -36

2-10 2-11

― 62 ―

63

4 -20 EBM 2 3PICO (Patient Intervension Comparison Outocome)

-19 UpToDate Dynamed 2-22

EBM 6 20 -30EBM

EBM

EBM

EBM

-20 PhaseⅡ Clinical ClerkshipⅠ Pre-c.c -19 PhaseⅡ Clinical ClerkshipⅠ Ⅱ -22 PhaseⅡ Clinical ClerkshipⅡ C.C. -30 PhaseⅠ Ⅱ

― 63 ―

64

-36

M4 -34

HAL Cyberdyne

-36 -34 M4

― 64 ―

65

•

•

PBL

PBL

1 9

-26 29 30

― 65 ―

66

1 5

5 6

9 PBL

1 2

TBL

― 66 ―

67

-26 Phase Ⅰ & -29 Phase Ⅰ Ⅰ -30 Phase Ⅰ Ⅱ

1

201426 2

-26 29 30

― 67 ―

68

-26 Phase Ⅰ & -29 Phase Ⅰ Ⅰ -30 Phase Ⅰ Ⅱ

iPS RNACRISPR

Ⅳ M4

Q 2.2.1

― 68 ―

69

PBL

iPS CRISPR

FD FD

•

― 69 ―

70

•

3 Ⅲ-1

-31

― 70 ―

71

Ⅲ-2 32014

-32 5 -23

2-122015 27

Ⅲ 2016 28Ⅲ

-31 Ⅲ-1 -32 -23 CC

2-12 46

37-40.2015

― 71 ―

72

M3 13 Ⅰ Ⅱ ⅢM5 M6 18 -30 -24

M3 13 ⅠⅡ

Ⅲ

M618 M5

2016 28

M5 M4

-30 Phase Ⅰ Ⅱ p.40 45 M3

― 72 ―

73

-24

M1 Ⅰ M2 Ⅱ

M3 13 ⅢM4

Pre-CC M4 2014 26

M6 20

2016 28

― 73 ―

74

M3 13 Ⅰ

Ⅱ ⅢM6

M6 18 20-30 -35

-30 Phase p.40 45 M3

-35 Phase #18 p.34 36

3 13 Ⅲ

IT M6

― 74 ―

75

M3 13

20

B 2.4.1 B 2.4.3

M3 13 Ⅰ

3

2-13

B 2.4.1 B 2.4.3

2-13 26 M3 13 Ⅰ

― 75 ―

76

M3 13 Ⅰ

/

•

•

•

― 76 ―

77

•

•

•

― 77 ―

78

6

Phase 1

2 3

― 78 ―

79

4

Pre-CC

Student Doctor

4

82007

19 1 1CC CC

CC 8 × CC4 ×

CC8 6 78 -19 2-14 49 5 8 (48 ) CC 6 5

9 6 4 (32 ) CC CC 6 5 6 6

CC 2-15

CC 4 5 7 8

CC 4

2-16

M2 M3

― 79 ―

80

CC Ⅴ

CC CC

4 2 6 CCCC

-22

CC

6 11

B2.8.1CC -23 2-18

― 80 ―

81

CC

B2.8.11

6

6 6 7 OSCE 6 20

-35

2

2

4

PBL M1 M35 1 5

PBL

― 81 ―

82

1 PBL

PBL

78

3 2CC 19

30

30

CC

― 82 ―

83

CC CC CC2015 27 16CC 1 1 CC8 6

27 CC 2 1CC 8

2015 27

2016 28 M42 4

8 42-17

WG

― 83 ―

84

FD

800

-19 Phase Ⅱ Clinical Clerkship Ⅰ Ⅱ

2-14 Ⅰ Ⅱ 2-15 2-16

-22 Phase Ⅱ Ⅱ CC -23 CC

2-18 -35 PhaseⅢ

2-17

― 84 ―

85

B 2.5.1 1 1

1 2 3B 2.5.3

4 78-27 31

1 3 4 6

1 2 4 62

12

M2 M3

-27 Ⅰ -31 Ⅲ

― 85 ―

86

3( ) -31

1( )

CC

2006 18GP Good Practice

-6

2015 27

-31 Ⅲ -6

― 86 ―

87

B 2.5.1 2 4

2 4 2CC 1 2

CC3 4

4

4 2B 2.5.1

2016 28 4 B 2.5.1

2-19

-20

B

― 87 ―

88

115 6

2-20( -19)

M4 Pre-CC

2 222 1 DVD 2-5

PCME

PCME

-20 Phase Ⅱ Clinical Clerkship Ⅰ Pre-CC 2-19 2-20

― 88 ―

89

-19 Phase Clinical Clerkship 2-5

4

-34

M4

M4

-34

― 89 ―

90

2025 37M2 Ⅱ

Ⅲ-1Ⅲ-2

-28 -31 -32

-28 Ⅱ -31 Ⅲ-1 -32 Ⅲ-2

B 2.5.1B 2.5.2

13

B 2.5.3 4 6

― 90 ―

91

1 3 4

2

1 2

2

C

1

24

1 4

1 BLS 4 ACLS4 Pre-CC

― 91 ―

92

B 2.5.1

•

•

•

•

•

― 92 ―

93

Phase Ⅰ Phase Ⅱ Phase ⅢPhase B.2.1.1

Phase ⅠB.2.1.2

2-21

2-4

3

5 6

6

18

― 93 ―

94

B 2.1.1

M2-29

PCME

2015 27 FD

PCME

Ⅱ Ⅲ/

B 2.4.1

WG

2017 29

-26 -36

2-21 Phase Ⅰ 2-4

3 -29 Phase Ⅰ Ⅰ

― 94 ―

95

B 2.6.1

B 2.6.1

B 2.6.1

B 2.6.1

B 2.6.1

B 2.6.1

B 2.6.1

B 2.6.1

― 95 ―

96

8

5

-34 2-22

5 6

CC CC ×

4

/ -36

1) 2 3 4 Maf

5 (WPI-IIIS) 6) β 7) · 8)

― 96 ―

97

9) 10 ·

11) 12) 13) 14) 15)

16) 17) 18) · 19) 20) 21

28

B 2.5.1CC Advanced CC 8

16

-34 2-22 2015

― 97 ―

98

-36

4 2 M4

41 1

2015 27 30

4

•

•

― 98 ―

99

•

•

5

― 99 ―

100

B 1.2.12-23

2-23

B 1.2.1 B 2.7.1

2015 27 7 6

B 1.2.1 B 2.7.1 2-23

2-23

― 100 ―

101

B 2.7.1PCME B 6.5.1

2004 16

2-23

2-23

B 1.2.1 B 2.7.1

― 101 ―

102

2015 27 7

B 1.2.1B 2.7.1 2-23

2-23

•

•

― 102 ―

103

10

JA

JA

2-24 1. 2. − − 3. 4.

M5 CC

9 1 6CC

-23

― 103 ―

104

3

ST

27.7

― 104 ―

105

( )

( )

( )

( ) ( )

Q 2.8.1

PCME

-23 CC

2-24

23B 7.3.2

PCMEFD

2012 24

― 105 ―

106

FD

2012 24 2015 27

2015 27 7 15

2015 27 7

SP

― 106 ―

109

•

•

•

•

•

•

•

•

― 109 ―

110

-23 -24 Tsukuba Web-based Information

Network System TWINS TWINS

25 GPA TWINS GPAA+ A B C D GPA P

FA+ A B C D 2013 25

A B C D 3-1 3 PBL(Problem based

learning )

M6

4

3-2

― 110 ―

111

M21

CBTMCQ M2 8

M3

4 5 9-19 1. 2.

3. 4. 5. 6. 7. 8. 9.

GPA A+ A-E

-19 A+ E

M4 M5 1

8

M6 7OSCE 4

5 5 126 6 CC CC

M6

― 111 ―

112

M6 4 6

-25 6

M6 6 11 20MCQ 8 11 12 3

2 MCQPCME 6

M1 M3

Tsukuba Web-based Information Network System

TWINSPCME

/

520 2

9

OSCE CBT

― 112 ―

113

1

12 3

1 21

2013 25

GPA 4 55 2014

26 9 B

8

-2SD○○

1) 2)

3) 4) ( ) 1 4

2015 27

( )

― 113 ―

114

201628

CC A+ D

2016 28 M4 M5

1

CC

+B 1.4.1

-23 -24

3-1 GPA 3-2

-19 Phase Clinical Clerkship p10,11 -25

B 3.1.1 3-3

― 114 ―

115

3-4 2014 26

― 115 ―

116

6

PCME 6

Advanced OSCE 1

4

FD 2 3FD 2

272012 24 2013 25

FD FD 201628 FD 3-5

6

Mini-CEX workplace-based assessment 360

FD

― 116 ―

117

3-3 3-4 3-5 26 PCME

B 3.1.1 B 3.1.2

1 OSCE3-3

Key feature

B 3.1.1 B 3.1.2

FD FD

B 1.4.12

― 117 ―

118

3-3

16 12

PCME

3-6

C

― 118 ―

119

3-6

4 CBT OSCE

CBT OSCE

2015 27 7

PCME

M6 OSCE

1 3 M6 SD

2 8 3

12

― 119 ―

120

4 CBT OSCE

CBT OSCE

M6OSCE OSCE

OSCE

OSCE M6

3-7

6

M6 MCQ

M6OSCE

OSCE 60

OSCE

― 120 ―

121

B 3.1.1

3-7

2007 19miniCEX

3-8 M1 Team-based Learning IRAT individual readiness assessment test GRAT group readiness assurance test

PBLTriple jump

Key features TBL IRAT GRAT TBL

TBL

Triple jump

― 121 ―

122

3-8 CC

CBT OSCE

PCME

C

Triple jump

Step2 60

Step1:15

SP

Step3 15

1 31 100 20

Step1

― 122 ―

123

•

•

•

B 1.1.1 1.

2. 3.

― 123 ―

124

4.

B 3.1.1 3-3 1)

PBL

M6OSCEM6 20 3

MCQ 2) M1 M5

12 4

3)

4)

M4 Pre-CC

3)

WG B 1.4.1 201527 7 B 3.1.1

― 124 ―

125

WG

3-3

WG B 1.4.12015 27 7

B 3.2.1

― 125 ―

126

M1 M5 CC

23

PBL

TBL1 2 M4

TBL IRAT GRATIRAT

2

TBL IRAT

TBL 201527

FD

― 126 ―

127

B 3.1.11

-23

B 3.1.1

FD

C

-23

― 127 ―

128

1

-23

M6

-5

1

-23 -5

― 128 ―

129

B 3.2.4 1 2

5

2

2

CC

― 129 ―

130

C

― 130 ―

133

•

•

•

•

•

•

― 133 ―

134

4-1( )

― 134 ―

135

2015-27 -28

121 63 36

22 ( )

( ) -2

― 135 ―

136

2 2/25 26

2

II B B

5

B B B

1

2

I A II B

II

2

( )1

(1) A (2) (

2 ) ()

-28 B 4.1.3

2015

― 136 ―

137

2006 18 10

2

2009 21 52011 23 2016 28 36

3610

1

2009 3 5 0 108 2010 0 7 0 110 2011 0 9 1 113 2012 0 11 1 115 2013 0 13 1 117 2014 0 22 1 126 2015 0 28 1 132 2016 ( ) 0 36 1 140

4-3

4-2

― 137 ―

138

4

4-2

2014 26

1 2

― 138 ―

139

2021 33

4-1

-2 p.107 p104 107

-27 27 -28

4-2 4-3

― 139 ―

140

19701990

PC2001 13

2007 19 Office for Students with Disabilities : OSD

OSD

4-4

4-5 • DVD

200

― 140 ―

141

2004 16 3

4-6

4-5

― 141 ―

142

4-7

4-4 Office for Students with Disabilities :OSD http://www.human.tsukuba.ac.jp/shien/support/index.html 4-5 4-6

http://www.dinf.ne.jp/doc/japanese/prdl/jsrd/norma/n332/n332020.html 4-7 2014 9 160 P.9

2 2016 28

-28

― 142 ―

143

5 2

(1) ( ) 28 3 31

(2) 28 3 31 2 62

(3) 104 4 1

28 3 31 (4) 16 28 3 31

(5)

16 28 3 31

1 25

150 190 4-2

6

C

― 143 ―

144

-28

4-2

B 1.1.1

-12

6 “Student

Doctor”

― 144 ―

145

B 4.1.1

4-8

2014 260.77

201123 4-9

― 145 ―

146

23 5

IR

201527

― 146 ―

147

-12

4-8 4-9 23

2009 215 (B 4.1.1 )

( ) -2

4-10 4-11 4-12

C

-2 ( )

4-10 http://www.pref.ibaraki.jp/hokenfukushi/iryo/ishi/isei/ishikakuho/top/

― 147 ―

148

4-11 4-12

•

-28 -27

10

3

A B C

029(853)6007

― 148 ―

149

“ ”

-27 -28

•

•

― 149 ―

150

4-3

1975 50 1977 52 2008

20 2009 21 2014 26 2015 27(Q 6.1.1 )

80037,000 1,300

93 380 62

50 147 6 7

B 5.1.1 B 6.1.1

5(B 6.1.1 )

― 150 ―

151

140 4A134 CBT 4A321 132

4A211-1 128

2015 27 4 1 731425 0.58 (B5.1.1 ) 2014 26

121 2010 22 10615 2

4-13

― 151 ―

152

4-3 4-13 HP

http://www.hosp.tsukuba.ac.jp/chiiki/

200921 4-3

4-11

(4-10)

2014 2638 22

50 2012 24

― 152 ―

153

C

4-3 4-10 HP http://www.pref.ibaraki.jp/hokenfukushi/iryo/ishi/isei/ishikakuho/top/index.html 4-11

•

•

•

•

•

― 153 ―

154

• • •

4-14

(1) (2) (3) (4) (5)

1 20 18

2 23 72

― 154 ―

155

2

PCME

1

4-14

4-15

― 155 ―

156

(4-16)

11 12 24

2009 2010 2011 2012 2013 7 11 18 12 19 7 30 59 89 94

PCME

― 156 ―

157

4-14

http://www.tsukuba.ac.jp/campuslife/unions/class.html 4-15

https://www.tsukuba.ac.jp/campuslife/studentplaza.html 4-16

http://www.hokekan.tsukuba.ac.jp/

4-17

― 157 ―

158

2009 21

3

25 4-18

5

2009 2010 2011 2012 2013

( ) 47 42 35 36 55

( ) 90 90 88 82 88

21 24 27 27 19

158 156 150 145 162

(Q 4.2.1 ) 151 6

― 158 ―

159

10 104-10

OSCE

B

8,000

6,830 ( )B 6.1.1

C

4-17 http://www.tsukuba.ac.jp/campuslife/scholarship.html

4-18 http://www.shihoukai.gr.jp/ 4-10 HP http://www.pref.ibaraki.jp/hokenfukushi/iryo/ishi/isei/ishikakuho/top/index.html

― 159 ―

160

2007 19

(B 4.3.1 ) 3

(B 4.3.1 )4-16

C

4-16 http://www.hokekan.tsukuba.ac.jp/

4-15

4-162 4-19

FD

― 160 ―

161

C

4-15 https://www.tsukuba.ac.jp/campuslife/studentplaza.html

4-16 http://www.hokekan.tsukuba.ac.jp/

4-19

PCMELAN

1 9 2 1 PCMETWINS https://twins.tsukuba.ac.jp/

D

4-19 2

FD

― 161 ―

162

PCME

4-19

4 6 M6 1 6

4-20 6 8

― 162 ―

163

2

M6

4-20 M6

•

•

― 163 ―

164

CC 8

CC ‘ ’CC

4-21

1

2

PBL ( ) PBL ( )

3

4

M4OSCE

― 164 ―

165

5

6

1993 2006

PCME

PCME

― 165 ―

166

4-22

C

4-21 PBL

http://igaku.md.tsukuba.ac.jp/kyoiku-culc/kyoiku-culc002 4-22

4-23 1978 53

2

18 8

― 166 ―

167

4-24 5

TIMSA4-25

5740 33

4-26

4-27 4-28

2 1

4-18

4-23 4-24

http://www.stb.tsukuba.ac.jp/~taiikukai_md/index.html 4-25

― 167 ―

168

http://www.stb.tsukuba.ac.jp/~bunsa/wiki/doku.php?id=index 4-26

http://www.stb.tsukuba.ac.jp/~geisa/intro.html 4-18

http://www.shihoukai.gr.jp/index.php 4-27

http://www.sohosai.tsukuba.ac.jp/ 4-28

http://www.meikei.or.jp/

― 168 ―

171

•

•

― 171 ―

172

2000 2001 12 132004 16

34

32007 19

3 5-1 5-25-3 5-4 3

― 172 ―

173

JREC-IN 200719 5

5-52002

14 52014 26 5

5

2015 27 4 1 706 425 3000.6

0.42 2014 26 121 201022 106 15

2

23 1 66 0 5 1 94

24 5 62 4 3 1 89 13 3 152 26 2 1 167 31 3 37 9 4 1 72

2 2 1 1 0 0 3 93 318 14 425

― 173 ―

174

I V

(B 2.4.1 )

5-1 5-2 5-3 5-4 5-5

― 174 ―

175

200921

2009 21

3 45-6

2013 252014 26

SS Best Faculty Member

― 175 ―

176

2015 27

TRIOS

FD

5-6

B 5.1.3

5-7

5-8

B 5.1.2

― 176 ―

177

5-7 5-8 HP

102

55 5-9

FDGP

5-10

2009 21

52015 27 25

― 177 ―

178

2011 23 3

2012 24 41 2 2

2015 27 7 7 69

2 2015 27 GPS

1 1 4

5 14

2 25

2 5

3 2

1 4 0

― 178 ―

179

5−9 HP

http://www.hosp.tsukuba.ac.jp/chiiki/ 5-10 HP

http://igaku.md.tsukuba.ac.jp/gp/gp4

5

5-11

5-12 2

- (2011 GP

)

― 179 ―

180

3

5-11 5-12

•

― 180 ―

181

•

•

(B 5.1.2 )

C

― 181 ―

182

2009 21

3 4

(B 5.1.2 )

PBL

― 182 ―

183

FD

C

2 3

PBL PCME

3 FD 2 2

FDFD GP

5-13

Student Doctor

― 183 ―

184

FD5 FD

2010 2011 2012 2013 2014 FD 18 22 21 20 40

FD 33 27 98 61 61

FD FD

FDFD

FD

FD

2011 GP -FD

5-13 FD

FDFD

FD

― 184 ―

185

PCME5-14

5-155-16

PCME(5-17) 6

TAPCME B 6.5.1

3 4

PCME

FD PCME

PCME

― 185 ―

186

5-14

http://www.tech.tsukuba.ac.jp/igaku-tech.html 5-15 PCME

http://www.tech.tsukuba.ac.jp/2005/report/05_Abe_Mayumi_Report_2005.pdf 5-16

http://www.tech.tsukuba.ac.jp/2013/report2013/report16.pdf 5-17 PCME

http://www.tech.tsukuba.ac.jp/2005/report/04_Morita_Rinko_Report_2005.pdf

2015 27 77 69 (Q 5.1.1 )

2015 27 4 1 731425 ( ) 0.58

(B 5.1.1 )

2

― 186 ―

187

5

( )

― 187 ―

188

― 188 ―

191

•

•

•

2

4km 1km 2,570,000 m2

5

162,245m2 33,688m2

1973

― 191 ―

192

24A

-1

4A

― 192 ―

193

(4A B ) (1 3 )6-1

(m2)

4A

103 30 84

104 30 84

203 134 129

204 134 129

304 134 129

B 202 150 205

203 120 205

(4A ) (1 3 )6-1

(m2)

4A111

140 338

4A121 121

150 409

4A211-1 211

128 428

4A303-1

36 98

4A311-1 311

128 399

4A321-1

132 263

― 193 ―

194

(4 6 )

(m2)

A 306 316

B 164 180

C 164 180

D 156 146

(4A ) (1 4 ) PBL

OSCE 13

(m2)

1 7 10 28

8 10 25

9,10 10 30

11 10 35

12,13 10 28

(4D ) (1 3 ) PBL

(m2)

1 2 20 50

3 20 41

1 8 21

2 6 8 20

― 194 ―

195

(122 m2) (4A303, 129 m2)

(6-3)

4A 1 7 104 m2 PCME 4A 3

PCME (m2) 6 118

7 60

1978 1 20142,793m2 1,904m2 349 6

2258 31,60023,000

9 22194,211 (

12,771 ) 28,7173

10 6-4

― 195 ―

196

(HP http://www.s.hosp.tsukuba.ac.jp/index.html)

3 1976 10

800 ( 759 41 )2013

1

Q 5.1.1

JA

1 1 4

5 14

2 25

2 5

3

― 196 ―

197

2

1 4 0

IT

PC 1,100 3 107( 41 4A 16 B 50 ) PC

e- 4A 4B365 24

9 22 ( 9 20 )

4A321 CBT 1324A121 22 PBL

1 PC

4A 20 4A103,104 6

1 13 13 1

4D( ) 17 1 9 2 9

e-

OSCEmanaba manaba 2014 26

moodle IDWeb

6-5

PC

― 197 ―

198

4B A D

9

TV

TV

(150 )

― 198 ―

199

UpToDate, Dynamed, Cochrane Library

B 9LAN

PC

5km 1km

1977

2005 17 8

8,400 (1 23 )

( HP http://www.tsukuba.ac.jp/campuslife/healthlife.html)

603,430 2 153 251

― 199 ―

200

18,000 6,830 (

) 1/3

1 1

E 1

1 2 1 1 11 5 7 1 2

( )

( HP http://www.tsukuba.ac.jp/campuslife/facilities/)

294-0045 2861 TEL.0470-22-1942

401-0502 479 TEL.0555-62-0309

― 200 ―

201

2.6% 5.9%7.8% 18.0%

11.6% 10.1% 75.5% 57.6%12%

4A134 4A

128 150 1402014 140 156 164

PBL23 140 PBL

4A 103 3 104 3

1 13 13

4D 1 2 2 2

23

PBL

― 201 ―

202

TBL Pre- CC B 202 203TBL

TBL

22 24

24 ICT TV

CC

A 4A 221

TBL 4A211160

4 5B 9 E

F 22 24

TV

5

― 202 ―

203

-1 24 723 6-1 6-2 6-3 6-4

-2 196 197 6−5 manaba

2004 16 4

(http://anzenmon.jp/category/tsukuba) Web

6-6 6-7

1) 2) 3) Tsukuba-CRIS

4) 5) 6)

― 203 ―

204

2013 25

(6-11)

1 2 1 4 3 4

2 2 4 5 2

HBs

6-8

A (IS 0.3 )-2

― 204 ―

205

1 (4A ) 2010

4A 2

2014 26

3

2014 26

-2

6-9

IC

Web

― 205 ―

206

PCME6-10 6-11 6-12

-19 100

FD

C

-2 191 -2 196

6-6 6-7 6-8 HP http://www.hokekan.tsukuba.ac.jp/ 6-9 6-10 6-11 6-12

-19 Phase Clinical Clerkship p.13-15

― 206 ―

207

(4A )

103 30 80

2008 2009

104 30 80

203 134 124

204 134 124

304 134 124

A 306 306

2014 B 164 140

C 164 140

D 156 4Z202 202 150 96

2006 4Z203 203 120 96

4A111 140 120 2008

4A121 121 150 130

4A211-1 211 160( ) 128 2015

4A303-1 36 2008

4A311-1 311 160( ) 128 2015

4A321-1 149( ) 132

2014 26

12 LAN

PC 10

― 207 ―

208

F

2015 24

(Endoscopy AccuTouch System)

GP

GP

2003 GP

2006 GP-6

2007 GP-7

- 2011 GP) -8

140156 4A 134

CBT 4A321 1324A211-1 128

F 800m2

GP 15

3Center of Planning and Coordination for Medical Education

PCME

2006 18

― 208 ―

209

2007 192 3

2011 23-

TV

1404A

4A211 311 274A221 27

C

-6

http://www.md.tsukuba.ac.jp/gendaigp/index.html -7

http://www.md.tsukuba.ac.jp/tokushokugp/index.html -8 -

http://igaku.md.tsukuba.ac.jp/gp/gp4

― 209 ―

210

•

•

1 1,655 89.2%225 26(CC) ( -19 6-13)

― 210 ―

211

CC1 1

CC2 4 4 1 8

CC (

CC) 8 CC 16 common disease

-23 CC CC

CC PCME

-6 6

2010

CC 8 CC common diseaseCC

― 211 ―

212

-11

e-

e-

PCME IR

-19 Phase Clinical Clerkship 6-13 CC

-23 CC -6 CC -11

CC (B 6.1.1 )

CC 6-14

― 212 ―

213

1

common disease

B 6.1.1

B 6.1.1

CCCC 8

common disease

CC

― 213 ―

214

4A 3031 F 1

CC

2 44

CC

-24 150

F

6-14 HP

http://pcmed-tsukuba.jp/area/ibaraki/ -24

CC1 CC

6-15

― 214 ―

215

(PCME) 6 4 CC

CC CC

PHS

PCME(B 6.1.2 6-10)

FD

6-15 CC 6-10

― 215 ―

216

CC 2 CCCC

6-16

CC B 6.2.21 CC

CCCC

― 216 ―

217

6-17

C

6-16 2014 M5 CC 6-17

•

•

― 217 ―

218

•

2007 19

161,100 PC

3 107 (41 4A 16 B 50 ) PC (IC )

PCLAN

LAN PCPC 23,000

UpToDate-2

manaba OSCE

― 218 ―

219

(B 6.1.1 )

ICT

24 ICTPBL

PC PC

4A PC 5 ICT

ICT

C

-2 192

107PC

PC 23,000

UpToDate

― 219 ―

220

PC5

ICTICT

e-

manaba e-

UpToDate The Best Evidence Clinical Evidence

PCLAN

LANPC

e-IP

(B 6.3.1 )

2015 27

― 220 ―

221

1

C

( HOPE EGMAIN) ID6-18

6-19PC

6-20

PC

27 6

C

― 221 ―

222

6-18 (Ver1)

http://www.s.hosp.tsukuba.ac.jp/innai/kojinhogo/ 6-19 6-20

4 5ID

― 222 ―

223

•

•

•

•

3

― 223 ―

224

C

PBL 4EBM 5

CC

― 224 ―

225

4A (1 4 )

(m2)

4A111

140 338

4A121 121

150 409

4A211-1 211

128 428

4A303-1

36 98

4A311-1 311

128 399

4A321-1

132 263

― 225 ―

226

35

HP-10

CC EBM

PBL4 EBM 5

― 226 ―

227

2016 28 4

-10 2013

15 6

4

2014 2014 26 6-21

― 227 ―

228

6-21 2014

•

•

•

•

•

― 228 ―

229

2004 16

3

3

(PCME)

PCME PBL

6-22 FD(Faculty Development)2014

26 FD

― 229 ―

230

FD 2014 5 26 2014 11 6

FD 3 2014 11 12 2014 12 18 FD 2014 7 16 2015 1 29

2015 1 16 2015 1 21 2014 26 FD

2 CC

CC CCPCME

PCME

B 2.1.1

PCME 12 5 7 136 7 PCME

6-23

55 MEDC in 2015 1

Team-based learning TBL Interprofessional education IPE

53 MEDC in 2014 8

49 MEDC in 2013

“ ”

46 MEDC in 2012 (IPE)-

40 MEDC in 2011 5 PBL

29 MEDC in 2008 8 PBL meets simulation

PCME

― 230 ―

231

Unit

1976 512001 13

PCME

1998 10-9

PCME

3 FD PCMEPCME

A

PCME

― 231 ―

232

PCME 2

1

-9

6-22 Vol.26 26-32 1995 6-23 PCME

B 6.5.1

2004 16

6-17

PCME

― 232 ―

233

1

( )

( )

( )

SP

(B 1.2.1 )

PCME

C

― 233 ―

234

6-17

B 6.5.2 PCME

6-24 6-25 6-166-26 6-27

PCME

C

6-24 M1 M2 M3 6-25 M4 6-16 M5 CC 6-26 M5 6-27

― 234 ―

235

PCME FDFD 2 3 FD 2

6-28 PBL

PCMEFD 6-29

PBLFD 6-27

FD 3

FD 2014 26 FD

6-30

FD FD

2FD

FD

FD FD

6-28 2015 FD 6-29 FD 6-27 6-30 FD

― 235 ―

236

PCME

1981 5613

1992 4

1998 10

2001 13 200214 2008

2009 2(MEDC)

2008 20 PBL 201123 (IPE)

2014 26 12 41

2010 22 10 1st Asia-Pacific Joint PBL conferencePBL in interprofessional integration: experiences from the interprofessional

education program of the University of Tsukuba -problems & resolutions-

(WFME, GMC, FAIMER, AMEE, AAMC )

― 236 ―

237

C

PCME B 6.5.1

PCME

PCME

C

•

― 237 ―

238

Interprofessional education IPE

5

2 Team-based Learning (TBL)3

Inter-professsional PBL

Team-based Learning (TBL) 2011

2IPE

― 238 ―

239

PBL TBL2013 25

12618 2014

26 4 TBL 1

21 2

(Readiness Assurance Process:RAP) 5(IRAT) GRAT GRAT

2

2006 18

2010 22

8 9

Interprofesssional PBL

12 1

‘ ’

2008 20

( ) ( )(USA) ( ) ( )

― 239 ―

240

6-31 6-32 6-33

PCME

IPE

6-34

6-31 ( ) ( ) ( ) 6-32 6-33 6-34

― 240 ―

241

2014 26

1

5 6 10

TOEFL iBT (80 )6-35

1030 2

( ) ( )

― 241 ―

242

(USA) ( ) ( )

2015 27

1

2013 25 Tsukuba Global Science Week (TGSW)

9 3 2013 25Cesario

2014 266-36

Campus-in-Campus

6-35 2016 M6 6-36 HP http://www.jsps.go.jp/j-sgu/index.html

― 242 ―

243

( ) ( ) (USA)

( ) ( )

― 243 ―

247

•

•

•

•

― 247 ―

248

PCMEOSCE CBT

PCME

PCMEB 1.2.1, B 6.5.2

-22 7-1

± CBT OSCE

― 248 ―

249

M6 8 1 12 2

3

PBL 7-2

1993 5 2003

15 2006 182011 23

2B 7.3.2 7-3 7-4

PCME

2013 25108 7-5 1980 55 33

― 249 ―

250

7-6

7-8

B 1.2.1 7-7

PCME IR

7-1 7-2

-22

― 250 ―

251

-9 5 1 14 7-3 15 18 7-4 23 7-5 108 7-6 1980 7-7 7-8

2010

M4M2 M3 PBL

-332 3

6

2014 26

2015 27

2015 27IB IB

IB1

1

― 251 ―

252

1

common disease CBT OSCE

CBT 2014 26 4 2015 279

2014 26 IRT 432015 27 CBT

M4

PCME

PCME5 7 2014 26

7-9

CBT 3

CBT CBT

CBT

FD CBT2010

― 252 ―

253

22 FDPCME

FD7-10

2018 30 4

2 4GTEC-CBT TOEFL-iBT TEAP IELTS

British Council

TOEFL-iBT2 3

4

CBT OSCEIB

4

-33 Phase

7-9 7-10 FD

± CBT

― 253 ―

254

OSCE ±

6 Advanced OSCE± 5 6

±

-23 6 8 1 12 2

5 6 10

7-11 7-12

7-13

PCME

IR

IR

― 254 ―

255

PCME IR

-23

7-11 7-12 7-13

7-14 1

1 3 4CC CC CC

7-15 2

6 10 3-

― 255 ―

256

USMLE

7-16 6

A

A 1

5 64

10 /

6 5 8

― 256 ―

257

1 2 5

4

7-14 7-15 7-16

PCME

FD

FD

M17-17

PCME

― 257 ―

258

PCME IR

7-17 M1

1973 48

B 7.1.1

2004 161984 59

6 30 150

― 258 ―

259

(Q 5.1.17-18)

2018 30

TOEFL 6 Advanced OSCE

7-18

― 259 ―

260

-26 -36

58

7-194

1 7-201 1 2

1

2004 1/38 4 ×2

6 2 ×3

Grade Point Average (GPA)

GIO SBO

4

(7-21)

― 260 ―

261

7-19 7-20 7-21

26 36

CBT OSCEUSMLE

2013 25 1087-5 1980 55 33

7-6CBT OSCE

-14 -15 6 Advavnced OSCEUSMLE

USMLE 3 610 USMLE

5 8 80 90

― 261 ―

262

CBT OSCE

6 advanced OSCE

2012 24

PCME

PCME IR

10

7-5 108 7-6 1980

-14 CBT -15 OSCE

― 262 ―

263

10 175.7 237.8

6 47 46 2010 22

6

2009 21

2009 212010 22

2011 232012 24

2012 2469 Q 5.1.1

201527 3

10 5.3% (8.9 ) 1 4.4% 3

201830 4

2013 25 13 2014

― 263 ―

264

26 22 2015 27 286

2015 27

•

•

PCME

― 264 ―

265

(7-22)

1 3

(7-8) 7 10 11 1 12 15

4 Pre-CC CBT OSCE CC 6 CC

CC

1 3(7-8)

1(7-23) 1 3

1

7-24 4OSCE Pre-CC

(7-25) 45 CC

CC CC7-19

CC CC 7-26

― 265 ―

266

6 M67-27

3

―

4

1 31 6 2 9 3 13

100 4 OSCE CC

― 266 ―

267

PCME PCME IR

7-22 HP 7-8 7-23 7-24 7-25 M4 7-19 7-26 M5 CC 7-27 M6

PCME

4 OSCE CC

(7-28 7-26)

PCMEPCME

7-29

― 267 ―

268

1

7-24

7-28 M4OSCE 7-26 25 M5 36 CC 7-29 7-24

― 268 ―

269

•

•

•

― 269 ―

270

98 90 4 5

7-31

7-31

7-30

7-30

― 270 ―

271

2004 161

Problem-Based Learning (PBL)

12

78 3

CBT

-14 M5

2012 243

― 271 ―

272

5 1 99 6 8 9

(31 )

N=75 87.2% (31 )

7-6

PBL

8 6

4

― 272 ―

273

5 10

PCME PCME IR

-14 CBT 7-6 1980

2008 20

1

2013 2513 2014 26 22 2015 27 28

― 273 ―

274

7-31SP

69Web manaba

B 6.1.1 GIO SBO

PCME

7-31

― 274 ―

275

21

2005 17 45

1973 48

5 60 10 50

1050

( )

2015 273

3

2004 16

9

― 275 ―

276

( )

PCMEIR

TOEFL-ITP

TOEFL-iBT

2015 272016 28 4

2018 30

2015 27

201 2015

27 3 4

― 276 ―

277

22015

27

CBT OSCE

PCME IR

http://www.tsukuba.ac.jp/admission/ -28 2015 27 5 7

― 277 ―

278

2 3622 2

63 57 2

2015 27 IB

15 9

2 2

― 278 ―

279

-28 27

PCME

IR

― 279 ―

280

7-12

7-13

7-33

25 2

7-32

― 280 ―

281

7-12 7-13 7-33

•

•

7-32

― 281 ―

282

B 7.2.1

4CC

PCME

1 7-7

7-7

PCME

― 282 ―

283

CC OSCE

PCME

PCME

― 283 ―

284

PCME

55 45

2012 24 7-32003

15 2006 18 7-4

― 284 ―

285

7-3 23 7-4 15 18

2012 24

PCME

IR

― 285 ―

289

•

•

•

2004 162013 25

― 289 ―

290

1

2

()

PCME

8-1 8-2

PCMEPCME

C

8-1 8-2

― 290 ―

291

2004 16

FDFD FD 3

PCME OSCE CBT

-22

CC

( 22 8-3 8-4 8-5 8-6 8-7)

― 291 ―

292

2014 26

Tsukuba Evaluation Support System for Professors' Achievement TESSA TESSA

8-8

PCME IR

-22 8-3 8-4 8-5 8-6 OSCE 8-7 8-8 TESSA

― 292 ―

293

25

PCME(8-9 8-10)

8-11 PCME

8-12

8-13

8-9 8-10 8-11

― 293 ―

294

8-12 8-13

1 CC CC

8-14

GP-6 -7

2012 248-15

― 294 ―

295

8-14

6 7

8-15 23

8-16 1

8-17

8-16 HP 8-17

― 295 ―

296

•

•

-318-18

2

PCME

― 296 ―

297

8-13

-31

8-18 p.12 13 8-13

2004 168-19 -2 -3 2

2 20102015

― 297 ―

298

1

8-20 8-21 8-22 8-23

201527

8-19

-2 -3

8-20 26 8-21 2 8-22 27 8-23 26

•

•

― 298 ―

299

•

•

GP 8-24 8-25

― 299 ―

300

C

8-24 GP 8-25

1,000

JA14

Q 5.1.1 8-26

( 800 / / )

― 300 ―

301

B 8.3.1

8-26

8-21

8-21 2

― 301 ―

302

2013 25

WPI 2012 24

14(B 6.1.1 8-26)

8-26

― 302 ―

303

•

•

PCMEPCME 5 13

― 303 ―

304

B 6.5.1

PCMEOSCE CBT

SD FD 8-27

PCME

PCMESD FD

PCME IR

8-27 SD FD

PCME B 8.4.1

PCMEPCME

― 304 ―

305

PCME

PCME

8-19-2

1

8-19

-2

― 305 ―

306

•

•

14 60

(8-28 8-29) CC CC

― 306 ―

307

8-14

Q 8.1.3

B 7.1.1-5 8-13

C

8-28 8-29 8-14 8-13

14

― 307 ―

308

M3-31

8-13

-31 8-13

― 308 ―

311

•

•

•

•

•

•

― 311 ―

312

•

2004 16

22 2010 22 2015

27

1

2(

)

PCME (B 8.1.1 )

1

1 8

― 312 ―

313

( 7 )

B 7.1.1-5

2 2010 22 2015 279-1

9-2 -22

― 313 ―

314

B 9.0.1 B 6.5.2

9-1 9-2

-22

― 314 ―

315

GP 9-3PCME

9-3 GP

Phase Ⅰ

PCME7-8

9-4

― 315 ―

316

PBLPCME PCME

PCME

TBLFD

9-5

PCME

100

PCME

PCME

― 316 ―

317

7-8 9-4 9-5 FD

Q 9.0.1B 2.1.1

B 9.0.1 2015 27

C

― 317 ―

318

B 1.1.1

2015 27

B 1.2.1 B 6.5.2

C

(31 ) 24 3

5 1 9

― 318 ―

319

9 6 8 9

N=75 87.2% (31 )

6

20 10

common disease

― 319 ―

320

2015 27

B 1.2.1 B 6.5.2

C

B 2.1.1TBL

PCME

TBLe-learning

2015 27 B 1.2.1

PCME

― 320 ―

321

FD

C

B 2.6.1

/ Q 2.3 Q 2.4 Q 2.5

2015 27

C

3

― 321 ―

322

3

3

Workplase-based assessmentPCME

C

B 4.1.1 (B 4.1.2 B 4.1.3 )

B 4.1.1B 4.2

― 322 ―

323

C

B 5.1 B 5.2

JA 14

Q 5.1.1 5-9 FD 9-5

5-9 9-5 FD

― 323 ―

324

B 6.1-6.3

5 6 8

1 140 TBL

2015 27 4A 221TBL 4A211160

C

PCMEOSCE CBT

B 7.1-7.3

― 324 ―

325

B 1.2.1 B 6.5.2

C PCME IR

2004 16

( )

― 325 ―

326

2013 25

/

C

― 326 ―

327

27 8 1

― 327 ―

医学教育分野別評価基準日本版 v1...医学教育分野別評価基準日本版v1.30...

Documents